T. Rowe Price Associates

T. Rowe Price Associates’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

T. Rowe Price Associates’s Portfolio FSTX Stock Details FSTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$398K	Hold
2022 Q3	$323K	Sell
2022 Q2	$3.82M	Sell
2022 Q1	$2.8M	Sell
2021 Q4	$4.31M	Buy
2021 Q3	$6.03M	Sell
2021 Q2	$7.11M	Buy